[Evaluation of insulin sensitivity: the HOMA and CIGMA models] by Levy, J

Insulin signalling through ultradian oscillations. by Levy, J

Evaluation of insulin sensitivity: the HOMA and CIGMA models by Levy, J

Therapeutic intervention in the GLP-1 pathway in Type 2 diabetes. by Levy, J

Gut hormones, incretin mimetics and gliptins: new understanding and novel therapies in type 2 diabetes. by Munro, N, Levy, J

Notes on the GENNID Study. by Turner, R, Levy, J

Erectile dysfunction in diabetes mellitus. by Malavige, L, Levy, J

Impending type 2 diabetes. by Matthews, DR, Levy, J

A Return to a Strong Presidency by Skach, C, Levy, J

Real gains but practical limitations to glycaemic control with insulin in type 2 diabetes by Gardner, S, Dunachie, S, Levy, J

Limitations of the microalbumin/creatinine ratio in detecting early microalbuminuria in type 1 diabetes by Karunakaran, S, Morris, R, Levy, J

An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study. by Wallace, T, Levy, J, Matthews, DR

The updated HOMA model: comparison of performance against euglycaemic and hyperglycaemic clamps by Wallace, T, Levy, J, Matthews, DR

Use and abuse of HOMA modeling. by Wallace, T, Levy, J, Matthews, DR

The incretin pathway as a new therapeutic target for obesity. by Barber, T, Begbie, H, Levy, J

The updated HOMA model: Comparison of performance against euglycemic and hyperglycemic clamps. by Wallace, T, Levy, J, Matthews, DR

The characteristics of men with diabetes seen in an erectile dysfunction clinic in the UK by Malavige, L, Ryan, E, Levy, J

Development of an in silico model to extrapolate whole body glucose - insulin homeostasis by altering tissue specific effects, simulation of SGLT-2 inhibition in type 2 diabetes by Hill, N, Levy, J, Matthews, D

Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166). by Gribble, F, Manley, SE, Levy, J

Complex genetics of type 2 diabetes: thrifty genes and previously neutral polymorphisms. by Turner, R, Levy, J, Clark, A